Business Context and Reporting Period
This Form 6-K filing by ORIX Corporation (TSE: 8591; NYSE: IX) is dated August 5, 2026. The report discloses the status of a share repurchase program for the month of July 2026. ORIX is a global financial services group operating in approximately 30 countries with a diverse portfolio including financing, insurance, banking, and asset management.
Key Financial Metrics
The filing focuses exclusively on share repurchase activity and does not provide consolidated revenue, profit, cash flow, or debt metrics for the period.
- Shares Repurchased (July 2026): 6,034,300 common shares
- Cost of Repurchase (July 2026): JPY 38,801,136,400
- Cumulative Shares Repurchased (as of July 31, 2026): 12,385,000 shares
- Cumulative Cost (as of July 31, 2026): JPY 78,448,326,300
Material Changes and Program Details
The repurchase activity is part of a broader program approved by the Board of Directors on May 11, 2026. Key parameters of the program include:
- Authorization Limit: Up to 100,000,000 shares (approx. 9.1% of outstanding shares excluding treasury shares).
- Authorization Cap: Up to JPY 250 billion.
- Program Duration: May 22, 2026, to March 31, 2027.
- Method: Market purchases via discretionary dealing contracts.
As of July 31, 2026, the company has utilized approximately 31.4% of the authorized share count and 31.4% of the authorized capital limit.
Guidance, Outlook, and Risks
The filing contains no specific financial guidance or management commentary regarding future earnings or operational outlook. It includes a standard caution concerning forward-looking statements, noting that actual results may differ materially due to risks described in the company's Form 20-F and previous Form 6-K filings regarding risk factors.
Investor Verification Checklist
- Verify the remaining authorization under the share repurchase program (approx. 87.6 million shares and JPY 171.6 billion).
- Review the Form 20-F and prior Form 6-K filings for detailed risk factors and consolidated financial results for the fiscal year ended March 31, 2026.
- Confirm the impact of the repurchase on earnings per share (EPS) and return on equity (ROE) in upcoming quarterly reports.